Forums Stock Picks Which stock pick should we analyze next?

Tagged: 

Viewing 15 posts - 16 through 30 (of 64 total)
  • Author
    Posts
  • Packer H Member
    Post count: 21

    REITS are trading at a low, how about Realty Income symbol O

    Justin L Newbie
    Post count: 2

    Hey Stig, could you analysis Signet Jewelers ticker symbol SIG or Icahan Enterprises ticker symbol IEP?

    DavidDavid Moderator
    Post count: 166

    Hi Justin,

    we have already done an analysis on SIG which you can find here;

    http://1nodld1ltmqu3jimmy2xsgcu-wpengine.netdna-ssl.com/wp-content/uploads/2018/03/SIG-Intrinsic-Value-v2.pdf

     

    Regards,

     

    David

     

     

    Austin D Newbie
    Post count: 2

    Hi Stig,

    Do have any thoughts on Fibrocell ticker symbol FCSC? They are entering phase 2/2 clinical trials and have FDA Fast Track, Rare Pediatric Disease, and Orphan Drug designations with the FDA. The company is located in Exton PA.

    Thanks,
    Austin Dunn

    Austin D Newbie
    Post count: 2

    Hi Stig,

    Do have any thoughts on Fibrocell ticker symbol FCSC? They are entering phase 2/2 clinical trials and have FDA Fast Track, Rare Pediatric Disease, and Orphan Drug designations with the FDA. The company is located in Exton PA.

    Thanks,
    Austin

    Gerard G Newbie
    Post count: 2

    Could you analyze Dollar General (DG). It has continued success over the past decade and i am close to pulling the trigger on it. With a discount rate of 5% I calculated an intrinsic value around $65. Its currently selling for $95 so its just a waiting game for me niw.

    Nick M. Member
    Post count: 23

    Hey Stig and David,

    Amazing job on your analyses of investments!

    We have good coverage of larger cap stocks.It would be great to see and analysis of some of the smaller players, where the playground is not as crowded by institutional investors and banks.

    For example, Live Ventures Incorporated (LIVE) – currently it is cheap based on EV/EBIT and a multitude of other value metrics, in addition to gaining a bit of positive momentum and bullish insider signals.

    Cheers,
    Nick

    DavidDavid Moderator
    Post count: 166

    Hi Nick,

     

    At present we have been focused on Large Caps as they are more liquid, are covered by most brokers and tend to garner more interest from readers etc. I’ll speak to Preston and Stig to see if we can begin to cover some smaller cap stocks.

     

    Regards,

    David

    Nick M. Member
    Post count: 23

    Much appreciated David!!

    Adam S Newbie
    Post count: 4

    Looking at LCI, “40 acquisitions over the last 15 years” (quote directly from CEO on website). Appears that they have grown their company by buying others. My question would be what opportunity is their for organic growth and sustainment? May be plenty, just curious.

    Now, on the contrary, with that acquisition rate their long term debt to equity is under 15% and their current ratio is 2.31 so they appear to have done some things financially “smart”. Now in their line of business an acquisition could be relatively cheap due to them buying small mom and pop fab shops but none the less they did it without generating a lot of debt. I also like their product sectors cover a diverse mix of a lot of different industries and consumer bases that could shield them from some sour markets in certain sectors. Comparing this to THOR’s IV report that I just read and the % of populous partaking in the recreational vehicle (RVing mainly) hobby I believe this is one that I will be looking at closer. I would be interested to see what the TIP group’s insight on IV and long term prospects would be for this one.

    -Adam

    Emanuele Z Member
    Post count: 14

    Your best idea I guess 🙂

    Ryan Y Newbie
    Post count: 3

    Philip Morris

    DavidDavid Moderator
    Post count: 166

    Hi Ryan,

    Preston and Stig have chosen to omit tobacco stocks from the IV Index for ethical reasons, this does not mean that they think they are bad investments though.

    By all means you can start a thread on the company here on the forum and I’ll be happy to contribute to it.

    Regards,

    David

    drulee Newbie
    Post count: 1

    AxoGen $AXGN is one I’ve been watching. Can you guys do analysis of the intrinsic value for this one? It’s a company that supplies peripheral nerve grafts which is used widely in surgical repairs that involve reconstruction for sensation/function. I believe it’s the only company out there that offers 7cm nerves (Advance) and is basically the gold standard when left with the choice of going after the patient’s own nerve in the leg. We use it in the face in my surgical practice, especially for benign and sometimes malignant pathologies.

    I think it’s a great stock pick, but is it too expensive to buy right now?

    Thanks in advance!

    DavidDavid Moderator
    Post count: 166

    Hi drulee,

    After taking a quick look at AXGN the following springs to mind,

    The company has yet to turn a profit, one must value on other metrics such as revenues, it currently has an EV/Revenue of 27.74 which is very high indeed.

    Share count has been rising dramatically leading to dilution of equity

    D/E currently stands at 0.82 which is of concern

    Now the market may be pricing the firm with such high multiples becasue it expects huge growth in the future and beleievs the firm has some significant competitive advantages. This may all turn out to be true but, in my opnion, paying such a high multiple for an early stage company seems extremely risky indeed. In this situation I’d put this stock on the too hard pile as I wouldn’t be comfortable getting an IV for it, I would then perhaps revist the firm in a few years once it became profitable to see how the situation had developed.

    Regards,

    David

Viewing 15 posts - 16 through 30 (of 64 total)

You must be logged in to reply to this topic.